Cargando…

CSF profile in primary progressive multiple sclerosis: Re-exploring the basics

OBJECTIVE: The aim of this study was to report the basic cerebrospinal fluid (CSF) profile in patients with primary progressive multiple sclerosis (PPMS). METHODS: The results of CSF analysis from 254 patients with PPMS were collected at four university hospitals in Germany. Routine CSF parameters a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdelhak, Ahmed, Hottenrott, Tilman, Mayer, Christoph, Hintereder, Gudrun, Zettl, Uwe K., Stich, Oliver, Tumani, Hayrettin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5552348/ https://www.ncbi.nlm.nih.gov/pubmed/28797088 http://dx.doi.org/10.1371/journal.pone.0182647

Ejemplares similares

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
por: Abdelhak, Ahmed, et al.
Publicado: (2019)

Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis
por: Robinson, Tilman, et al.
Publicado: (2020)

Primary Progressive Multiple Sclerosis: Putting Together the Puzzle
por: Abdelhak, Ahmed, et al.
Publicado: (2017)

The MRZ reaction in primary progressive multiple sclerosis
por: Hottenrott, Tilman, et al.
Publicado: (2017)

Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
por: Petereit, Hela-Felicitas, et al.
Publicado: (2021)

Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study
por: Abdelhak, Ahmed, et al.
Publicado: (2020)

Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?
por: Abdelhak, Ahmed, et al.
Publicado: (2015)

Immunological findings in psychotic syndromes: a tertiary care hospital's CSF sample of 180 patients
por: Endres, Dominique, et al.
Publicado: (2015)

Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies
por: Huss, André, et al.
Publicado: (2020)

CSF oligoclonal IgG bands are not associated with ALS progression and prognosis
por: Klose, Veronika, et al.
Publicado: (2023)

CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort
por: Senel, Makbule, et al.
Publicado: (2019)

The intrathecal, polyspecific antiviral immune response in neurosarcoidosis, acute disseminated encephalomyelitis and autoimmune encephalitis compared to multiple sclerosis in a tertiary hospital cohort
por: Hottenrott, Tilman, et al.
Publicado: (2015)

Screening for onconeural antibodies in neuromyelitis optica spectrum disorders
por: Berger, Benjamin, et al.
Publicado: (2017)

A Score Based on NfL and Glial Markers May Differentiate Between Relapsing–Remitting and Progressive MS Course
por: Huss, André, et al.
Publicado: (2020)

The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis
por: Dersch, R, et al.
Publicado: (2015)

The MRZ reaction helps to distinguish rheumatologic disorders with central nervous involvement from multiple sclerosis
por: Hottenrott, Tilman, et al.
Publicado: (2018)

Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases
por: Abu-Rumeileh, Samir, et al.
Publicado: (2020)

The TRACK-MS Test Battery: A Very Brief Tool to Track Multiple Sclerosis-Related Cognitive Impairment
por: Taranu, Daniela, et al.
Publicado: (2022)

Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis
por: Steinacker, Petra, et al.
Publicado: (2011)

Serum GFAP as a biomarker for disease severity in multiple sclerosis
por: Abdelhak, A., et al.
Publicado: (2018)

CSF Findings in Acute NMDAR and LGI1 Antibody–Associated Autoimmune Encephalitis
por: Dürr, Marc, et al.
Publicado: (2021)

Transient spurious intrathecal immunoglobulin synthesis in neurological patients after therapeutic apheresis
por: Berger, Benjamin, et al.
Publicado: (2015)

Repeated Intrathecal Triamcinolone Acetonide Administration in Progressive Multiple Sclerosis: A Review
por: Abu-Mugheisib, Mazen, et al.
Publicado: (2011)

Neurochemical Biomarkers in patients with COVID-19
por: Tumani, Hayrettin
Publicado: (2023)

Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis
por: Abdelhak, A., et al.
Publicado: (2019)

Spontaneous (Hashimoto-like) chronic lymphocytic thyroiditis in a rhesus macaque (Macaca mulatta)
por: Plesker, Roland, et al.
Publicado: (2021)

Epileptic seizures at multiple sclerosis onset and their role in disease progression
por: Grothe, Matthias, et al.
Publicado: (2023)

Stress cardiomyopathy associated with the first manifestation of multiple sclerosis: a case report
por: Rapp, Daniel, et al.
Publicado: (2020)

Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β
por: Hesse, Raphael, et al.
Publicado: (2016)

Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis—Report of Two Cases
por: Rau, Daniela, et al.
Publicado: (2015)

Clinical, MRI, and CSF Markers of Disability Progression in Multiple Sclerosis
por: Gajofatto, Alberto, et al.
Publicado: (2013)

CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer’s disease
por: Teuber-Hanselmann, Sarah, et al.
Publicado: (2020)

Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis
por: Senel, Makbule, et al.
Publicado: (2014)

Video basics 4 /
por: Zettl, Herbert
Publicado: (2004)

The pathophysiology of motor fatigue and fatigability in multiple sclerosis
por: Patejdl, Robert, et al.
Publicado: (2022)

Association of obesity with disease outcome in multiple sclerosis
por: Lutfullin, Isabel, et al.
Publicado: (2023)

Differentiating neurosarcoidosis from multiple sclerosis using combined analysis of basic CSF parameters and MRZ reaction
por: Vlad, Benjamin, et al.
Publicado: (2023)

CSF shunt re-infections in children
por: Sankhla, Suresh
Publicado: (2009)

Reduced cGMP levels in CSF of AD patients correlate with severity of dementia and current depression
por: Hesse, Raphael, et al.
Publicado: (2017)

Association of Serum GFAP with Functional and Neurocognitive Outcome in Sporadic Small Vessel Disease
por: Huss, André, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rfuvgotapgv4r1bemp5eis4t85